TRANSLATING THE BIOLOGY OF AGING INTO NEW THERAPEUTICS FOR ALZHEIMER’S DISEASE

 Howard Fillit (USA)

CRYO-EM STRUCTURES OF DISEASE FILAMENTS FROM HUMAN BRAINS

 Michel Goedert (UK)

THE GENETICS OF NEURODEGENERATIVE DISEASES – FROM RARE POPULATIONS TO COMMON VARIANTS

 Rita Guerreiro (USA)

ESCAPING DEMENTIA UNTIL EXTREME AGES: WHAT CAN COGNITIVELY HEALTHY CENTENARIANS TEACH US?

 Henne Holstege (The Netherlands)

A BIOLOGIC DEFINITION AND STAGING PLATFORM FOR NEURONAL SYNUCLEIN DISEASE

 Ken Marek (USA)

FROM LAB TO CLINIC: PROGRESS AND CHALLENGES IN ALPHA-SYNUCLEIN BASED THERAPIES FOR PARKINSON’S DISEASE

 Pamela McLean (USA)

MS TECHNOLOGIES FOR PLASMA BIOMARKER DEVELOPMENT